Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02406690 · ClinicalTrials.gov registry record
Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects
A clinical trial, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- 1
- Enrollment target
NCT02406690: Completed study, sponsored by Reproductive Medicine Associates of New Jersey.
NCT02406690 is a clinical trial that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02406690 has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the differences that exist in RNA molecules, the biochemical process of methylation, and estrogen receptor binding in patients that have failed to produce adequate endometrium in synthetic embryo transfer cycles when compared to patients whose endometrium thickness is within normal limits.
Interventions
- OTHER Estradiol Valerate, Progesterone in Oil, Leuprolide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-07-31 |
| Est. Completion | 2015-09-17 |
What the finished NCT02406690 record still lists
NCT02406690 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Estradiol Valerate, Progesterone in Oil, Leuprolide is the first listed.
NCT02406690 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02406690 about?
NCT02406690 is a clinical study titled "Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects". The purpose of this study is to determine the differences that exist in RNA molecules, the biochemical process of methylation, and estrogen receptor binding in patients that have failed to produce adequate endometrium in synthetic embryo transfer cycles when compared to patients whose endometrium th...
What is the current status of trial NCT02406690?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2015-07-31. Estimated completion is 2015-09-17.
What interventions are being tested in trial NCT02406690?
The interventions under investigation include: Estradiol Valerate, Progesterone in Oil, Leuprolide (OTHER).
Who is sponsoring clinical trial NCT02406690?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI